Evidence map›Paper›PMID 25667753›Full record

ArticleCentral European journal of urology2014

Pattern of prostate cancer presentation among the Egyptian population: A study in a single tertiary care center.

Ahmed Elabbady, Ahmed Eid, Ahmed Fahmy, Ahmed Fouad Kotb

Abstract read
In one paragraph

Article in Central European journal of urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Effect of ginger, chamomile, and green tea extracts on prostate cancer cells.Journal, genetic engineering & biotechnology · 2024
    Article
  5. Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective.Global journal on quality and safety in healthcare · 2023
    Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ahmed ElabbadyUniversity of Alexandria, Faculty of Medicine, Department of Urology, Alexandria, Egypt.
Ahmed EidUniversity of Alexandria, Faculty of Medicine, Department of Urology, Alexandria, Egypt.
Ahmed FahmyUniversity of Alexandria, Faculty of Medicine, Department of Urology, Alexandria, Egypt.
Ahmed Fouad KotbUniversity of Alexandria, Faculty of Medicine, Department of Urology, Alexandria, Egypt.
Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProstate cancer is a common health problem that in the majority of cases starts to develop at the age of 50 years, reaching its peak at 60-70 years of age. A variation in its incidence and prevalence exists between western, Asian and Arabic populations. The aim of our work was to report the pattern of prostate cancer presentation in Alexandria University that as a tertiary referral center provides care for uro-oncology cases. MATERIAL AND

methodsData collection for all patients diagnosed with prostate cancer at Alexandria University in Egypt through the year 2012 was done.

resultsThe mean age of the patients was 67. Mean serum total PSA, prostate volume and PSAd were 149 ng/ml, 63 grams and 3.1 ng/ml/gm respectively. 25% of patients were asymptomatic diagnosed accidentally during screening for prostate cancer. The remaining group was presenting with LUTS, including 23 patients who presented initially with back pain.

conclusionsEgyptian men with prostate cancer have a markedly high PSA density and Gleason grade at diagnosis.

Indexed as

Egyptian populationprostate cancerrisk stratification

Identifiers

PMID25667753
PMCPMC4310882
OpenAlexW2106137231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.